NCT03015532View on ClinicalTrials.gov

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

PHASE2CompletedINTERVENTIONAL

Enrollment

285

Participants

Timeline

Start Date

January 13, 2017

Primary Completion Date

April 20, 2018

Study Completion Date

May 16, 2018

Conditions

Postoperative Pain

Interventions

DRUG

HTX-011

HTX-011 (bupivacaine/meloxicam), via instillation

DRUG

Saline Placebo

Saline placebo via injection

DRUG

Bupivicaine HCl

Bupivacaine HCl without epinephrine

DRUG

Ropivacaine

Ropivacaine, via injection

Trial Locations (24)

33136

Miami

33143

Miami

33155

Miami

33321

Tamarac

35660

Sheffield

36608

Mobile

43203

Columbus

43210

Columbus

45417

Dayton

75093

Plano

77004

Houston

77027

Houston

77043

Houston

77401

Bellaire

77598

Webster

78209

San Antonio

78229

San Antonio

78240

San Antonio

85015

Phoenix

85023

Phoenix

89109

Las Vegas

92037

La Jolla

92103

San Diego

92503

Riverside

Sponsors

Lead Sponsor

Heron Therapeutics

All Listed Sponsors

lead

Heron Therapeutics

INDUSTRY